West Tower Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-124
Closed -$6.61K 258
2023
Q4
$6.61K Buy
124
+55
+80% +$2.68K 0.01% 398
2023
Q3
$3.43K Sell
69
-29
-30% -$1.62K ﹤0.01% 528
2023
Q2
$5.83K Buy
+98
New +$5.58K ﹤0.01% 497

Other funds holding GMED

West Tower Group's GMED Position: Q1 2024 in Review

West Tower Group sold out of Globus Medical (GMED) in Q1 2024, closing a stake of 124 shares — an estimated $6.61K sold.

West Tower Group first reported a position in GMED in Q2 2023 and held it in 3 quarters. The position peaked at $6.61K in Q4 2023. 439 funds tracked by Wall St. Rank hold GMED as of Q1 2024.

  • West Tower Group reported no remaining Globus Medical position as of Q1 2024 after selling out during the quarter.
  • West Tower Group sold 124 Globus Medical shares in Q1 2024, an estimated $6.61K.
  • West Tower Group first reported a position in Globus Medical in Q2 2023 and held it in 3 quarters.
  • West Tower Group's Globus Medical position peaked at $6.61K in Q4 2023.
  • 439 funds tracked by Wall St. Rank held Globus Medical as of Q1 2024.

Based on West Tower Group's 13F filing for Q1 2024, filed 14 May 2024.